﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xsi:schemaLocation="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-11-13T12:19:55-06:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmName>
        <BusinessNameLine1Txt>Foundation Source</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>3333 New Hyde Park Rd Ste 406</AddressLine1Txt>
        <CityNm>New Hyde Park</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>11042</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>814172003</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>Lytton-Kambara Foundation</BusinessNameLine1Txt>
      </BusinessName>
      <InCareOfNm>% Foundation Source</InCareOfNm>
      <BusinessNameControlTxt>LYTT</BusinessNameControlTxt>
      <PhoneNum>8008391754</PhoneNum>
      <USAddress>
        <AddressLine1Txt>Foundation Source 501 Silverside Rd</AddressLine1Txt>
        <CityNm>Wilmington</CityNm>
        <StateAbbreviationCd>DE</StateAbbreviationCd>
        <ZIPCd>198091377</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>laurence lytton</PersonNm>
      <PersonTitleTxt>president</PersonTitleTxt>
      <PhoneNum>8008391754</PhoneNum>
      <SignatureDt>2024-11-12</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>Jeffrey D Haskell</PreparerPersonNm>
      <PTIN>P01345770</PTIN>
      <PhoneNum>8008391754</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="11">
    <IRS990PF documentId="IRS990PF">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>63723357</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>26517886</ContriRcvdRevAndExpnssAmt>
        <InterestOnSavRevAndExpnssAmt>487622</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>487622</InterestOnSavNetInvstIncmAmt>
        <DividendsRevAndExpnssAmt>62475</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>62475</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>3742613</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>62709420</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>24011538</CapGainNetIncmNetInvstIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="OtherIncomeSch2">410102</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>410102</OtherIncomeNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>31220698</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>24971737</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>0</CompOfcrDirTrstRevAndExpnssAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="OthProfFeesSch">259</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesNetInvstIncmAmt>259</OtherProfFeesNetInvstIncmAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="TaxesSchedule">164200</TaxesRevAndExpnssAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="OtherExpensesSch">147607</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>22889</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>111287</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>312066</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>23148</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>111287</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>1491900</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>1491900</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>1803966</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>23148</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>1603187</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>29416732</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>24948589</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <SavAndTempCashInvstBOYAmt>12391572</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>8662801</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>8662801</SavAndTempCashInvstEOYFMVAmt>
        <AcctRcvblBOYAmt>1267</AcctRcvblBOYAmt>
        <OtherNtsAndLoansRcvblAmt>4100520</OtherNtsAndLoansRcvblAmt>
        <OtherNtsAndLoansRcvblBOYAmt>4000417</OtherNtsAndLoansRcvblBOYAmt>
        <OtherNtsAndLoansRcvblEOYAmt referenceDocumentId="OthNoteLoanRcvblLong">4100520</OtherNtsAndLoansRcvblEOYAmt>
        <OtherNtsAndLoansRcvblEOYFMVAmt>3205416</OtherNtsAndLoansRcvblEOYFMVAmt>
        <CorporateStockBOYAmt>18819415</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="InvestCorpStockSch">48627754</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>46765759</CorporateStockEOYFMVAmt>
        <CorporateBondsBOYAmt>979005</CorporateBondsBOYAmt>
        <CorporateBondsEOYAmt referenceDocumentId="InvestCorpBondsSch">630000</CorporateBondsEOYAmt>
        <CorporateBondsEOYFMVAmt>675681</CorporateBondsEOYFMVAmt>
        <OtherInvestmentsBOYAmt>5591925</OtherInvestmentsBOYAmt>
        <OtherInvestmentsEOYAmt referenceDocumentId="InvOtherSch2">7577377</OtherInvestmentsEOYAmt>
        <OtherInvestmentsEOYFMVAmt>4413700</OtherInvestmentsEOYFMVAmt>
        <TotalAssetsBOYAmt>41783601</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>69598452</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>63723357</TotalAssetsEOYFMVAmt>
        <OtherLiabilitiesBOYAmt>1601881</OtherLiabilitiesBOYAmt>
        <TotalLiabilitiesBOYAmt>1601881</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowFASB117Ind>X</OrgDoesNotFollowFASB117Ind>
        <RetainedEarningBOYAmt>40181720</RetainedEarningBOYAmt>
        <RetainedEarningEOYAmt>69598452</RetainedEarningEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>40181720</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>69598452</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>41783601</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>69598452</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>40181720</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>29416732</ExcessRevenueOverExpensesAmt>
        <SubtotalAmt>69598452</SubtotalAmt>
        <TotNetAstOrFundBalancesEOYAmt>69598452</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>Publicly-traded Securities</PropertyDesc>
          <GrossSalesPriceAmt>62392093</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>37289918</CostOrOtherBasisAmt>
          <GainOrLossAmt>25102175</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>25102175</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CYREN - 5.75% - 03/19/2024 - WRITE OFF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-03-17</AcquiredDt>
          <SoldDt>2023-03-30</SoldDt>
          <CostOrOtherBasisAmt>1000000</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1000000</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1000000</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-03</SoldDt>
          <GrossSalesPriceAmt>1241</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2267</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1026</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1026</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-03</SoldDt>
          <GrossSalesPriceAmt>3043</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2624</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2624</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-04</SoldDt>
          <GrossSalesPriceAmt>2122</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3842</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1720</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1720</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-05</SoldDt>
          <GrossSalesPriceAmt>3866</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6800</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2934</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2934</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-10</SoldDt>
          <GrossSalesPriceAmt>14103</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>18735</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4632</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4632</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-10</SoldDt>
          <GrossSalesPriceAmt>16706</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5961</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5961</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-11</SoldDt>
          <GrossSalesPriceAmt>7916</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>10212</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2296</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2296</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-11</SoldDt>
          <GrossSalesPriceAmt>9777</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12455</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2678</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2678</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-12</SoldDt>
          <GrossSalesPriceAmt>1070</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1133</CostOrOtherBasisAmt>
          <GainOrLossAmt>-63</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-63</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-12</SoldDt>
          <GrossSalesPriceAmt>2195</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2221</CostOrOtherBasisAmt>
          <GainOrLossAmt>-26</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-26</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-12</SoldDt>
          <GrossSalesPriceAmt>5112</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-555</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-555</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-12</SoldDt>
          <GrossSalesPriceAmt>6174</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6846</CostOrOtherBasisAmt>
          <GainOrLossAmt>-672</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-672</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-12</SoldDt>
          <GrossSalesPriceAmt>8830</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>9067</CostOrOtherBasisAmt>
          <GainOrLossAmt>-237</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-237</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-12</SoldDt>
          <GrossSalesPriceAmt>16125</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>17001</CostOrOtherBasisAmt>
          <GainOrLossAmt>-876</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-876</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-12</SoldDt>
          <GrossSalesPriceAmt>20280</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2387</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2387</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-12</SoldDt>
          <GrossSalesPriceAmt>20980</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1687</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1687</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>1023</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1133</CostOrOtherBasisAmt>
          <GainOrLossAmt>-110</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-110</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3468</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4534</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1066</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1066</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3617</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4533</CostOrOtherBasisAmt>
          <GainOrLossAmt>-916</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-916</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3617</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4533</CostOrOtherBasisAmt>
          <GainOrLossAmt>-916</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-916</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3711</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4533</CostOrOtherBasisAmt>
          <GainOrLossAmt>-822</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-822</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3721</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4533</CostOrOtherBasisAmt>
          <GainOrLossAmt>-812</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-812</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3772</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4534</CostOrOtherBasisAmt>
          <GainOrLossAmt>-762</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-762</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4050</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4534</CostOrOtherBasisAmt>
          <GainOrLossAmt>-484</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-484</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4068</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4533</CostOrOtherBasisAmt>
          <GainOrLossAmt>-465</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-465</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4138</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4534</CostOrOtherBasisAmt>
          <GainOrLossAmt>-396</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-396</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3653</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4578</CostOrOtherBasisAmt>
          <GainOrLossAmt>-925</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-925</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3713</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1954</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1954</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3749</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1918</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1918</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>3757</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1910</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1910</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4031</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1636</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1636</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4031</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1636</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1636</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4077</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5666</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1589</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1589</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4115</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1552</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1552</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4160</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1507</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1507</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4160</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5666</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1506</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1506</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4277</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1390</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1390</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4402</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1265</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1265</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4499</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1168</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1168</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>4510</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1157</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1157</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>6108</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6800</CostOrOtherBasisAmt>
          <GainOrLossAmt>-692</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-692</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>5215</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7933</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2718</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2718</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>8251</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>9067</CostOrOtherBasisAmt>
          <GainOrLossAmt>-816</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-816</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>6720</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>10200</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3480</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3480</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>9388</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>10201</CostOrOtherBasisAmt>
          <GainOrLossAmt>-813</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-813</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-13</SoldDt>
          <GrossSalesPriceAmt>17000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22667</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5667</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5667</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-17</SoldDt>
          <GrossSalesPriceAmt>2359</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3400</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1041</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1041</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-17</SoldDt>
          <GrossSalesPriceAmt>5775</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7934</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2159</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2159</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-18</SoldDt>
          <GrossSalesPriceAmt>2222</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3400</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1178</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1178</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA-PC - OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-01-20</SoldDt>
          <GrossSalesPriceAmt>1472</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2267</CostOrOtherBasisAmt>
          <GainOrLossAmt>-795</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-795</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-03-21</SoldDt>
          <GrossSalesPriceAmt>4300</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5666</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1366</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1366</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-03-21</SoldDt>
          <GrossSalesPriceAmt>4300</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>5666</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1366</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1366</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-03-21</SoldDt>
          <GrossSalesPriceAmt>8425</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11334</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2909</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2909</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OMEGA THERAPEUTICS, INC PFD SER C (LIFESCI SPV)</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-12</AcquiredDt>
          <SoldDt>2023-08-29</SoldDt>
          <GrossSalesPriceAmt>3933</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11334</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7401</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7401</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>24011538</CapitalGainNetIncomeAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>346785</InvestmentIncomeExciseTaxAmt>
        <SubtotalAmt>346785</SubtotalAmt>
        <TaxBasedOnInvestmentIncomeAmt>346785</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>136107</EstimatedPlusOvpmtIncmTxAmt>
        <ExemptFrgnOrgTaxWthldAtSrceAmt>0</ExemptFrgnOrgTaxWthldAtSrceAmt>
        <ExtsnRequestIncomeTaxPaidAmt>1400</ExtsnRequestIncomeTaxPaidAmt>
        <TotalPaymentsAndCreditsAmt>137507</TotalPaymentsAndCreditsAmt>
        <Form2220AttachedInd referenceDocumentId="IRS2220">X</Form2220AttachedInd>
        <EsPenaltyAmt>10953</EsPenaltyAmt>
        <TaxDueAmt>220231</TaxDueAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>false</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>false</MoreThan100SpentInd>
        <Form1120POLFiledInd>false</Form1120POLFiledInd>
        <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>false</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>true</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>true</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>DE</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>true</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>false</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>false</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>false</OwnControlledEntityInd>
        <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>true</ComplyWithPublicInspRqrInd>
        <PersonsWithBooksName>
          <BusinessNameLine1Txt>Foundation Source</BusinessNameLine1Txt>
        </PersonsWithBooksName>
        <PhoneNum>8008391754</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>55 WALLS DRIVE FL 3</AddressLine1Txt>
          <CityNm>Fairfield</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>06824</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>false</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>false</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>false</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>false</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>false</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>false</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>false</PaymentToGovernmentOfficialInd>
        <UncorrectedPriorActsInd>false</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>false</UndistributedIncomePYInd>
        <BusinessHoldingsInd>false</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>false</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>false</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>false</InfluenceLegislationInd>
        <InfluenceElectionInd>false</InfluenceElectionInd>
        <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>false</NoncharitablePurposeInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Janice Kambara</PersonNm>
          <USAddress>
            <AddressLine1Txt>Foundation Source 501 Silverside Rd</AddressLine1Txt>
            <CityNm>Wilmington</CityNm>
            <StateAbbreviationCd>DE</StateAbbreviationCd>
            <ZIPCd>198091377</ZIPCd>
          </USAddress>
          <TitleTxt>Dir</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.0</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Katherine Lytton</PersonNm>
          <USAddress>
            <AddressLine1Txt>Foundation Source 501 Silverside Rd</AddressLine1Txt>
            <CityNm>Wilmington</CityNm>
            <StateAbbreviationCd>DE</StateAbbreviationCd>
            <ZIPCd>198091377</ZIPCd>
          </USAddress>
          <TitleTxt>Dir</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.0</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Laurence Lytton</PersonNm>
          <USAddress>
            <AddressLine1Txt>Foundation Source 501 Silverside Rd</AddressLine1Txt>
            <CityNm>Wilmington</CityNm>
            <StateAbbreviationCd>DE</StateAbbreviationCd>
            <ZIPCd>198091377</ZIPCd>
          </USAddress>
          <TitleTxt>Dir, Pres, Sec, Treas</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>8.0</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>Foundation Source</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>55 Walls Drive 3rd Fl</AddressLine1Txt>
            <CityNm>Fairfield</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06824</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>Administrative</ServiceTypeTxt>
          <CompensationAmt>111262</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SummaryOfDirectChrtblActyGrp />
      <SumOfProgramRelatedInvstGrp />
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>45062329</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>11017759</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>6521532</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>62601620</TotalFMVOfUnusedAssetsAmt>
        <AcquisitionIndebtednessAmt>0</AcquisitionIndebtednessAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>62601620</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>939024</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>61662596</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>3083130</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>3083130</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>346785</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>346785</TotalTaxAmt>
        <DistributableBeforeAdjAmt>2736345</DistributableBeforeAdjAmt>
        <DistributableBeforeDedAmt>2736345</DistributableBeforeDedAmt>
        <DistributableAsAdjustedAmt>2736345</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>1603187</ExpensesAndContributionsAmt>
        <ProgramRelatedInvstTotalAmt>0</ProgramRelatedInvstTotalAmt>
        <CharitableAssetsAcquisPaidAmt>0</CharitableAssetsAcquisPaidAmt>
        <SetAsideSuitabilityTestAmt>0</SetAsideSuitabilityTestAmt>
        <SetAsideCashDistriTestAmt>0</SetAsideCashDistriTestAmt>
        <QualifyingDistributionsAmt>1603187</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>2736345</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>1582122</UndistributedIncomePYAmt>
        <QualifyingDistributionsAmt>1603187</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>1582122</AppliedToYear1Amt>
        <AppliedToCurrentYearAmt>21065</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>0</RemainingDistriFromCorpusAmt>
        <TotalCorpusAmt>0</TotalCorpusAmt>
        <UndistributedIncomeCYAmt>2715280</UndistributedIncomeCYAmt>
        <ExcessDistriCyovToNextYrAmt>0</ExcessDistriCyovToNextYrAmt>
        <ExcessFromCurrentYearAmt>0</ExcessFromCurrentYearAmt>
      </UndistributedIncomeGrp>
      <PrivateOperatingFoundationsGrp></PrivateOperatingFoundationsGrp>
      <SupplementaryInformationGrp>
        <ContributingManagerNm>Janice Kambara</ContributingManagerNm>
        <ContributingManagerNm>Laurence Lytton</ContributingManagerNm>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BOWDOIN COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4100 COLLEGE STA</AddressLine1Txt>
            <CityNm>BRUNSWICK</CityNm>
            <StateAbbreviationCd>ME</StateAbbreviationCd>
            <ZIPCd>04011</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Clare McWilliams Lyne Scholarship Fund</GrantOrContributionPurposeTxt>
          <Amt>20000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BRYN MAWR COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>101 N MERION AVE</AddressLine1Txt>
            <CityNm>BRYN MAWR</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19010</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Bryn Mawr Scholarship Fund</GrantOrContributionPurposeTxt>
          <Amt>25000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CENTRAL PARK CONSERVANCY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>717 FIFTH AVE</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10022</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>1000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GARDINER LIBRARY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>133 FARMERS TPKE</AddressLine1Txt>
            <CityNm>GARDINER</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12525</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>GOV</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>200</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HUDSON VALLEY RAIL TRAIL ASSOCIATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>TOWN HALL - 12 CHURCH ST</AddressLine1Txt>
            <CityNm>HIGHLAND</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12528</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>200</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KHAN ACADEMY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 1630</AddressLine1Txt>
            <CityNm>MOUNTAIN VIEW</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94042</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>1000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MOHONK PRESERVE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 715</AddressLine1Txt>
            <CityNm>NEW PALTZ</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12561</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>5000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATURAL RESOURCES DEFENSE COUNCIL INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>40 WEST 20TH ST 11TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10011</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>100000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NATURE CONSERVANCY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>4245 N FAIRFAX DRIVE STE 100</AddressLine1Txt>
            <CityNm>ARLINGTON</CityNm>
            <StateAbbreviationCd>VA</StateAbbreviationCd>
            <ZIPCd>22203</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>20000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK PUBLIC RADIO</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>160 VARICK ST</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW YORK-NEW JERSEY TRAIL CONFERENCE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>600 RAMAPO VALLEY RD</AddressLine1Txt>
            <CityNm>MAHWAH</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07430</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NORTHWELL HEALTH FOUNDATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2000 MARCUS AVE 2ND FL</AddressLine1Txt>
            <CityNm>NEW HYDE PARK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>11042</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Lenox Hill Hospital Research Laboratory of Dr. Richard L. Whelan fund</GrantOrContributionPurposeTxt>
          <Amt>1500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OPEN SPACE INSTITUTE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1370 BROADWAY 5TH FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10018</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>land conservation and greenway trail projects in the Shawangunk Mountain region of New York State</GrantOrContributionPurposeTxt>
          <Amt>950000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARKS &amp; TRAILS NEW YORK INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>33 ELK ST</AddressLine1Txt>
            <CityNm>ALBANY</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12207</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>300</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PITZER COLLEGE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1050 N MILLS AVE</AddressLine1Txt>
            <CityNm>CLAREMONT</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>91711</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>15000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PRO PUBLICA INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>155 AVE OF THE AMERICAS 13TH FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>RIVERKEEPER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>20 SECOR RD</AddressLine1Txt>
            <CityNm>OSSINING</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10562</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE FRIENDS OF THE GLOVERSVILLE PUBLIC LIBRARY INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>58 E FULTON ST</AddressLine1Txt>
            <CityNm>GLOVERSVILLE</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>12078</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>200</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TRUST FOR PUBLIC LAND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>666 BROADWAY 9TH FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10012</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>350000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WIKIMEDIA FOUNDATION INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 98204</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20090</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>General &amp; Unrestricted</GrantOrContributionPurposeTxt>
          <Amt>500</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>1491900</TotalGrantOrContriPdDurYrAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <FeesContractsFromGovtAgGrp />
        <MembershipDuesAndAssmntGrp />
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>487622</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>62475</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <NetRntlIncmReDebtFincdPropGrp />
        <NetRntlIncmReNotDebtFincdProp />
        <NetRentalIncomePersonalPropGrp />
        <OtherInvestmentIncomeGrp />
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>3742613</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <NetIncomeLossFromSpecialEvtGrp />
        <GrossProfitLossSlsOfInvntryGrp />
        <OtherRevenueDescribedGrp>
          <Desc>INTEREST INCOME FROM NOTES</Desc>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>410102</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <SubtotalsIncmProducingActyGrp>
          <ExclusionAmt>4702812</ExclusionAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>4702812</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>false</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>false</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>false</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>false</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>false</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>false</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>false</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>false</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>false</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>false</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <IRS990ScheduleB documentId="IRS990ScheduleB">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <GeneralRuleInd>X</GeneralRuleInd>
      <ContributorInformationGrp>
        <ContributorNum>1</ContributorNum>
        <ContributorPersonNm>Katherine Lytton 2014 Family Trust</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>467 Central Park West 17-A</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10025</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>915400</TotalContributionsAmt>
        <NoncashContributionInd>X</NoncashContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>2</ContributorNum>
        <ContributorPersonNm>Lytton Laurence</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>467 Central Park West 17-A</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10025</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>25172468</TotalContributionsAmt>
        <NoncashContributionInd>X</NoncashContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>3</ContributorNum>
        <ContributorPersonNm>William Lytton Trust</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>467 Central Park West 17-A</AddressLine1Txt>
          <CityNm>New York</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10025</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>430018</TotalContributionsAmt>
        <NoncashContributionInd>X</NoncashContributionInd>
      </ContributorInformationGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>1</ContributorNum>
        <NoncashPropertyDesc>Apollo Endosurgery APEN, 92000 sh.</NoncashPropertyDesc>
        <FairMarketValueAmt>915400</FairMarketValueAmt>
        <ReceivedDt>2023-02-03</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>2</ContributorNum>
        <NoncashPropertyDesc>Apollo Endosurgery APEN, 1333098 sh.</NoncashPropertyDesc>
        <FairMarketValueAmt>13257660</FairMarketValueAmt>
        <ReceivedDt>2023-02-07</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>2</ContributorNum>
        <NoncashPropertyDesc>Apollo Endosurgery APEN, 1199880 sh.</NoncashPropertyDesc>
        <FairMarketValueAmt>11914808</FairMarketValueAmt>
        <ReceivedDt>2023-03-09</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>3</ContributorNum>
        <NoncashPropertyDesc>IDEAL POWER ORD SHS IPWR, 15400 sh.</NoncashPropertyDesc>
        <FairMarketValueAmt>199738</FairMarketValueAmt>
        <ReceivedDt>2023-01-25</ReceivedDt>
      </NonCashPropertyContributionGrp>
      <NonCashPropertyContributionGrp>
        <ContributorNum>3</ContributorNum>
        <NoncashPropertyDesc>Apollo Endosurgery APEN, 23167 sh.</NoncashPropertyDesc>
        <FairMarketValueAmt>230280</FairMarketValueAmt>
        <ReceivedDt>2023-02-02</ReceivedDt>
      </NonCashPropertyContributionGrp>
    </IRS990ScheduleB>
    <DepreciationSchedule documentId="DepreciationSch" />
    <InvestmentsCorpBondsSchedule documentId="InvestCorpBondsSch">
      <InvestmentsCorporateBondsGrp>
        <BondNm>VERTEX ENERGY INC BOND 144A -</BondNm>
        <EOYBookValueAmt>630000</EOYBookValueAmt>
        <EOYFMVAmt>675681</EOYFMVAmt>
      </InvestmentsCorporateBondsGrp>
    </InvestmentsCorpBondsSchedule>
    <InvestmentsCorpStockSchedule documentId="InvestCorpStockSch">
      <InvestmentsCorporateStockGrp>
        <StockNm>ACM RESEARCH INC</StockNm>
        <EOYBookValueAmt>57009</EOYBookValueAmt>
        <EOYFMVAmt>105633</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AKOUSTIS TECHNOLOGIES INC</StockNm>
        <EOYBookValueAmt>2041900</EOYBookValueAmt>
        <EOYFMVAmt>619245</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALBIREO PHARMA - CONTRA</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALIMERA SER B PFD STOCK</StockNm>
        <EOYBookValueAmt>2260818</EOYBookValueAmt>
        <EOYFMVAmt>5830355</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALPINE IMMUNE SCIENCES</StockNm>
        <EOYBookValueAmt>12200</EOYBookValueAmt>
        <EOYFMVAmt>19060</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ALTO INGREDIENTS INC</StockNm>
        <EOYBookValueAmt>232728</EOYBookValueAmt>
        <EOYFMVAmt>314893</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AMRYT PHARMA ADR CONTRA</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AMRYT PHARMA ADR CVR</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>APPLIED THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>88388</EOYBookValueAmt>
        <EOYFMVAmt>123035</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>AQUESTIVE THERAPEUTICS ORD SHS</StockNm>
        <EOYBookValueAmt>5813</EOYBookValueAmt>
        <EOYFMVAmt>5446</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ASSERTIO THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>22000</EOYBookValueAmt>
        <EOYFMVAmt>21400</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ATYR PHARMA INC COM NEW</StockNm>
        <EOYBookValueAmt>1316279</EOYBookValueAmt>
        <EOYFMVAmt>824868</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BIONOMICS</StockNm>
        <EOYBookValueAmt>42490</EOYBookValueAmt>
        <EOYFMVAmt>5772</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>BIOTE CORP</StockNm>
        <EOYBookValueAmt>1278663</EOYBookValueAmt>
        <EOYFMVAmt>2105532</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CELLECTAR BIOSCIENCES COMMON W</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CELLECTAR BIOSCIENCES INC</StockNm>
        <EOYBookValueAmt>830838</EOYBookValueAmt>
        <EOYFMVAmt>1264516</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CELLECTAR BIOSCIENCES SER E3</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CELLECTAR BIOSCIENCES SER E4</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CIDARA THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>564661</EOYBookValueAmt>
        <EOYFMVAmt>320243</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>COHU INC</StockNm>
        <EOYBookValueAmt>314518</EOYBookValueAmt>
        <EOYFMVAmt>389042</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>COYA THERAPEUTICS INCORPORATED</StockNm>
        <EOYBookValueAmt>499950</EOYBookValueAmt>
        <EOYFMVAmt>606788</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>CY REN L TO SHS</StockNm>
        <EOYBookValueAmt>28750</EOYBookValueAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DARIO HEALTH PFD STOCK SER B</StockNm>
        <EOYBookValueAmt>2000000</EOYBookValueAmt>
        <EOYFMVAmt>1117762</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DELCATH SYSTEMS INC</StockNm>
        <EOYBookValueAmt>5700</EOYBookValueAmt>
        <EOYFMVAmt>7904</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DIAMEDICA THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>2807119</EOYBookValueAmt>
        <EOYFMVAmt>2255338</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>DUOS TECHNOLOGIES GROUP INC</StockNm>
        <EOYBookValueAmt>1005000</EOYBookValueAmt>
        <EOYFMVAmt>971500</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ELECTROVAYA INC</StockNm>
        <EOYBookValueAmt>1850223</EOYBookValueAmt>
        <EOYFMVAmt>1733885</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EMCORE CORP WARRANTS</StockNm>
        <EOYBookValueAmt>950000</EOYBookValueAmt>
        <EOYFMVAmt>2280000</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EMCORE CORPORATION</StockNm>
        <EOYBookValueAmt>2829250</EOYBookValueAmt>
        <EOYFMVAmt>1087523</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ENVVENO MEDICAL CORP</StockNm>
        <EOYBookValueAmt>1499998</EOYBookValueAmt>
        <EOYFMVAmt>1327934</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ENVVENO MEDICAL CORP-WARRANT A</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ENVVENO MEDICAL CORP-WARRANT B</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>EXAGEN INC COM</StockNm>
        <EOYBookValueAmt>366610</EOYBookValueAmt>
        <EOYFMVAmt>260304</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>FENNEC PHARMACEUTICALS INC</StockNm>
        <EOYBookValueAmt>38987</EOYBookValueAmt>
        <EOYFMVAmt>57918</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>GALERA THERAPEUTICS ORD SHS</StockNm>
        <EOYBookValueAmt>464074</EOYBookValueAmt>
        <EOYFMVAmt>32208</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>GIGA-TRONICS INC - WARRANT</StockNm>
        <EOYBookValueAmt>749999</EOYBookValueAmt>
        <EOYFMVAmt>36170</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>IDEAL POWER ORD SHS</StockNm>
        <EOYBookValueAmt>33722</EOYBookValueAmt>
        <EOYFMVAmt>20202</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>IO BIOTECH</StockNm>
        <EOYBookValueAmt>1836041</EOYBookValueAmt>
        <EOYFMVAmt>1704572</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>IO BIOTECH WARRANTS</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>KWESST MICRO SYSTEMS INC</StockNm>
        <EOYBookValueAmt>9074</EOYBookValueAmt>
        <EOYFMVAmt>3614</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>KWESST MICRO SYSTEMS INC WARRA</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>LIQTECH INTERNATIONAL INC</StockNm>
        <EOYBookValueAmt>1951754</EOYBookValueAmt>
        <EOYFMVAmt>155857</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>LISATA THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>11400</EOYBookValueAmt>
        <EOYFMVAmt>10319</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MDXHEALTH SPON ADS</StockNm>
        <EOYBookValueAmt>1210192</EOYBookValueAmt>
        <EOYFMVAmt>1192039</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MEDIWOUND</StockNm>
        <EOYBookValueAmt>7754</EOYBookValueAmt>
        <EOYFMVAmt>10170</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MKS INSTRUMENTS, INC</StockNm>
        <EOYBookValueAmt>9963</EOYBookValueAmt>
        <EOYFMVAmt>10287</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>MOLECULAR TEMPLATES INC</StockNm>
        <EOYBookValueAmt>1642305</EOYBookValueAmt>
        <EOYFMVAmt>868907</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NOTABLE LABS, INC</StockNm>
        <EOYBookValueAmt>16510</EOYBookValueAmt>
        <EOYFMVAmt>5099</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>NUVVE HOLDING CORP WARRANTS</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>OCULAR THERAPEUTIX</StockNm>
        <EOYBookValueAmt>487504</EOYBookValueAmt>
        <EOYFMVAmt>669000</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>OMNIQ CORP COMMON</StockNm>
        <EOYBookValueAmt>161931</EOYBookValueAmt>
        <EOYFMVAmt>14342</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>ORYZON GENOMICS</StockNm>
        <EOYBookValueAmt>32119</EOYBookValueAmt>
        <EOYFMVAmt>17731</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>OTONOMY INC</StockNm>
        <EOYBookValueAmt>20495</EOYBookValueAmt>
        <EOYFMVAmt>1884</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PLUG POWER INC</StockNm>
        <EOYBookValueAmt>1465</EOYBookValueAmt>
        <EOYFMVAmt>2250</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>PRECISION OPTICS</StockNm>
        <EOYBookValueAmt>799998</EOYBookValueAmt>
        <EOYFMVAmt>802665</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>QUICKLOGIC</StockNm>
        <EOYBookValueAmt>131584</EOYBookValueAmt>
        <EOYFMVAmt>354816</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SCIENTIFIC INDUSTRIES</StockNm>
        <EOYBookValueAmt>1300004</EOYBookValueAmt>
        <EOYFMVAmt>1249320</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SCIENTIFIC INDUSTRIES, INC - C</StockNm>
        <EOYBookValueAmt>891376</EOYBookValueAmt>
        <EOYFMVAmt>448503</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SCIENTIFIC INDUSTRIES, INC - W</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SCPHARMACEUTICALS INC</StockNm>
        <EOYBookValueAmt>3499264</EOYBookValueAmt>
        <EOYFMVAmt>2373546</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SEELOS THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>8068</EOYBookValueAmt>
        <EOYFMVAmt>231</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SOCIETAL CDMO, INC</StockNm>
        <EOYBookValueAmt>4873</EOYBookValueAmt>
        <EOYFMVAmt>5030</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SPECTRA7 MICROSYSTEMS INC</StockNm>
        <EOYBookValueAmt>1105624</EOYBookValueAmt>
        <EOYFMVAmt>322788</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>SPECTRA7 MICROSYSTEMS WARRANTS</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>STRYVE FOODS INC WARRANTS</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>TELA BIO INC</StockNm>
        <EOYBookValueAmt>5580</EOYBookValueAmt>
        <EOYFMVAmt>6620</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>THERATECHNOLOGIES INC</StockNm>
        <EOYBookValueAmt>1500000</EOYBookValueAmt>
        <EOYFMVAmt>2430000</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>UROGEN PHARMA LTD</StockNm>
        <EOYBookValueAmt>1676050</EOYBookValueAmt>
        <EOYFMVAmt>2445855</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>VISTAGEN THERAPEUTICS, INC.</StockNm>
        <EOYBookValueAmt>332184</EOYBookValueAmt>
        <EOYFMVAmt>317637</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>VYNE THERAPEUTICS INC</StockNm>
        <EOYBookValueAmt>999999</EOYBookValueAmt>
        <EOYFMVAmt>999999</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>X4 PHARMACEUTICALS</StockNm>
        <EOYBookValueAmt>999999</EOYBookValueAmt>
        <EOYFMVAmt>551644</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>XERIS BIOPHARMA HOLDINGS INC</StockNm>
        <EOYBookValueAmt>636890</EOYBookValueAmt>
        <EOYFMVAmt>1315523</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>XTANT MEDICAL HOLDINGS INC</StockNm>
        <EOYBookValueAmt>3140067</EOYBookValueAmt>
        <EOYFMVAmt>4731035</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <InvestmentsOtherSchedule2 documentId="InvOtherSch2">
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>BIOS ACTUATE CO-INVEST III, LP</CategoryOrItemTxt>
        <BookValueAmt>486569</BookValueAmt>
        <EOYFMVAmt>500000</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>LIFESCI VENTURE SPV XIII LLC</CategoryOrItemTxt>
        <BookValueAmt>1200001</BookValueAmt>
        <EOYFMVAmt>1200000</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>LIQTECH INTL INC</CategoryOrItemTxt>
        <BookValueAmt>2969300</BookValueAmt>
        <EOYFMVAmt>233700</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>MAXONA PHARMACEUTICALS, INC. P</CategoryOrItemTxt>
        <BookValueAmt>1000000</BookValueAmt>
        <EOYFMVAmt>1000000</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>MAKO MEDICAL LABS SERIES F</CategoryOrItemTxt>
        <BookValueAmt>1721507</BookValueAmt>
        <EOYFMVAmt>1280000</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>RETENSION PHARMACEUTICALS SER</CategoryOrItemTxt>
        <BookValueAmt>200000</BookValueAmt>
        <EOYFMVAmt>200000</EOYFMVAmt>
      </InvestmentsOtherGrp>
    </InvestmentsOtherSchedule2>
    <OtherExpensesSchedule documentId="OtherExpensesSch">
      <OtherExpensesScheduleGrp>
        <Desc>Administrative Fees</Desc>
        <RevenueAndExpensesPerBooksAmt>111262</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>111262</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Bank Charges</Desc>
        <RevenueAndExpensesPerBooksAmt>8226</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>8226</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>K-1 Exp BIOS ACTUATE CO-INVEST</Desc>
        <RevenueAndExpensesPerBooksAmt>13431</RevenueAndExpensesPerBooksAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>K-1 Exp LIFESCI VENTURE SPV XI</Desc>
        <RevenueAndExpensesPerBooksAmt>14663</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>14663</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>State or Local Filing Fees</Desc>
        <RevenueAndExpensesPerBooksAmt>25</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>25</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="OtherIncomeSch2">
      <OtherIncomeDetail>
        <Desc>Interest Income from Notes</Desc>
        <RevenueAndExpensesPerBooksAmt>410102</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>410102</NetInvestmentIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherNotesLoansRcvblLongSch documentId="OthNoteLoanRcvblLong">
      <OtherNotesLoansRcvblLongGrp>
        <BorrowerNameGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SPECTRA7 MICROSYSTEMS INC</BusinessNameLine1Txt>
          </BusinessName>
        </BorrowerNameGrp>
        <LoanOriginalAmt>2000417</LoanOriginalAmt>
        <BalanceDueAmt>2000417</BalanceDueAmt>
        <NoteDt>2022-07</NoteDt>
        <LoanMaturityDt>2024-12</LoanMaturityDt>
        <RepaymentTermsTxt>INT/PRIN DUE SEMI-ANNU&amp;ON MATURITY</RepaymentTermsTxt>
        <InterestRt>14.</InterestRt>
        <SecurityProvidedBorrowerTxt>NONE</SecurityProvidedBorrowerTxt>
        <LoanPurposeTxt>INVESTMENT</LoanPurposeTxt>
        <LenderConsiderationDesc>CASH 0 CASH 0 CASH 0</LenderConsiderationDesc>
      </OtherNotesLoansRcvblLongGrp>
      <OtherNotesLoansRcvblLongGrp>
        <BorrowerNameGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SPECTRA7 MICROSYSTEMS INC</BusinessNameLine1Txt>
          </BusinessName>
        </BorrowerNameGrp>
        <LoanOriginalAmt>600103</LoanOriginalAmt>
        <BalanceDueAmt>600103</BalanceDueAmt>
        <NoteDt>2023-09</NoteDt>
        <LoanMaturityDt>2025-06</LoanMaturityDt>
        <RepaymentTermsTxt>INT/PRIN DUE SEMI-ANNU&amp;ON MATURITY</RepaymentTermsTxt>
        <InterestRt>9.</InterestRt>
        <SecurityProvidedBorrowerTxt>NONE</SecurityProvidedBorrowerTxt>
        <LoanPurposeTxt>INVESTMENT</LoanPurposeTxt>
        <LenderConsiderationDesc>CASH 0 CASH 0 CASH 0</LenderConsiderationDesc>
      </OtherNotesLoansRcvblLongGrp>
      <OtherNotesLoansRcvblLongGrp>
        <BorrowerNameGrp>
          <BusinessName>
            <BusinessNameLine1Txt>STRYVE FOODS LLC</BusinessNameLine1Txt>
          </BusinessName>
        </BorrowerNameGrp>
        <LoanOriginalAmt>1500000</LoanOriginalAmt>
        <BalanceDueAmt>1500000</BalanceDueAmt>
        <NoteDt>2023-04</NoteDt>
        <LoanMaturityDt>2024-12</LoanMaturityDt>
        <RepaymentTermsTxt>PRIN AT MATURITY, INT ACCRD ANNU</RepaymentTermsTxt>
        <InterestRt>12.</InterestRt>
        <SecurityProvidedBorrowerTxt>NONE</SecurityProvidedBorrowerTxt>
        <LoanPurposeTxt>INVESTMENT</LoanPurposeTxt>
        <LenderConsiderationDesc>CASH 0 CASH 0 CASH 0</LenderConsiderationDesc>
      </OtherNotesLoansRcvblLongGrp>
    </OtherNotesLoansRcvblLongSch>
    <OtherProfessionalFeesSchedule documentId="OthProfFeesSch">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>Investment Management Services</CategoryTxt>
        <Amt>259</Amt>
        <NetInvestmentIncomeAmt>259</NetInvestmentIncomeAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <TaxesSchedule documentId="TaxesSchedule">
      <TaxesDetail>
        <CategoryTxt>990-PF Estimated Tax for 2023</CategoryTxt>
        <Amt>107700</Amt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>990-PF Extension for 2022</CategoryTxt>
        <Amt>56500</Amt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>